Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $214B | +$1.55B | 204 | 3.84% | Increased |
|
| 2 |
BlackRock
New York
| $185B | +$1.88B | 204 | 3.88% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $95.9B | +$1.26B | 185 | 3.9% | Increased |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $46.7B | +$648M | 216 | 3.78% | Increased |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $46.5B | +$1.44B | 160 | 2.83% | Increased |
|
| 6 |
Morgan Stanley
New York
| $40.9B | -$458M | 220 | 2.96% | Reduced |
|
| 7 |
T. Rowe Price Associates
Baltimore,
Maryland
| $38.3B | +$1B | 123 | 4.41% | Increased |
|
| 8 |
JP Morgan Chase
New York
| $33.7B | +$1.55B | 195 | 2.56% | Increased |
|
| 9 |
Wellington Management Group
Boston,
Massachusetts
| $33.6B | +$111M | 61 | 5.88% | Increased |
|
| 10 |
Bank of New York Mellon
New York
| $26.2B | -$671M | 142 | 4.87% | Reduced |
|
| 11 |
Norges Bank
Oslo,
Norway
| $26B | -$415M | 79 | 3.63% | Reduced |
|
| 12 |
Capital Research Global Investors
Los Angeles,
California
| $25B | +$719M | 20 | 5.19% | Increased |
|
| 13 |
Bank of America
Charlotte,
North Carolina
| $22.9B | +$535M | 223 | 1.84% | Increased |
|
| 14 |
Northern Trust
Chicago,
Illinois
| $21.5B | -$755M | 185 | 3.53% | Reduced |
|
| 15 |
Invesco
Atlanta,
Georgia
| $21.1B | +$292M | 120 | 4.08% | Increased |
|
| 16 |
Massachusetts Financial Services
Boston,
Massachusetts
| $21.1B | +$105M | 46 | 6.29% | Increased |
|
| 17 |
T. Rowe Price Investment Management
Baltimore,
Maryland
| $18.7B | -$25.2M | 30 | 11.29% | Reduced |
|
| 18 |
Franklin Resources
San Mateo,
California
| $17.7B | -$580M | 106 | 4.96% | Reduced |
|
| 19 |
UBS AM
Chicago,
Illinois
| $15.6B | -$134M | 102 | 4% | Reduced |
|
| 20 |
Charles Schwab
San Francisco,
California
| $14.8B | +$458M | 143 | 2.83% | Increased |
|
| 21 |
Goldman Sachs
New York
| $14.5B | +$36.8M | 144 | 2.34% | Increased |
|
| 22 |
Legal & General Group
London,
United Kingdom
| $14.4B | +$89M | 131 | 3.79% | Increased |
|
| 23 |
Capital International Investors
Los Angeles,
California
| $13.9B | -$874M | 9 | 2.67% | Reduced |
|
| 24 |
Dimensional Fund Advisors
Austin,
Texas
| $13.5B | +$409M | 130 | 3.28% | Increased |
|
| 25 |
Nuveen
Charlotte,
North Carolina
| $12.7B | -$166M | 130 | 3.57% | Reduced |
|